Back to search
SARS-CoV-2 Serological Status
Clinical trial pipeline · Data from ClinicalTrials.gov
See which SARS-CoV-2 Serological Status trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which SARS-CoV-2 Serological Status trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
COVID-19 is a new emerging disease caused by infection with the SARS-CoV-2 coronavirus, with no specific therapeutic options. Since the end of February 2020, t…
The purpose of this study is to define seroprevalence of anti-SARS-CoV2 among children of Hospital Workers in APHP, particularly exposed population, according t…
The objective of the COVID-HOP study is to identify biological and non-biological markers associated to: a positive or negative serology anti SRAS-Cov-2; a posi…